Proxy Statement

MADRIGAL PHARMACEUTICALS, INC. Filed 2011-04-29 Acc 0001047469-11-004245

Documents 1

2012-04-27 DEF 14A Proxy Statement
2011-05-05 ARS Annual Report to Security Holders
2011-05-05 10-Q Quarterly Report
2011-05-02 S-8 Securities Offered to Employees in Benefit Plans
2011-04-29 DEF 14A Proxy Statement
2011-04-26 4 Sr. VP, Drug Development sold 20,000 shares at an average $5.80 ($116,000)
2010-04-30 DEF 14A Proxy Statement

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading a2203641zdef14a.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…